| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |